Blue Jet Healthcare Limited has signed a Memorandum of Understanding (MOU) with the Andhra Pradesh Economic Development Board (APEDB). The company plans to invest approximately ₹500 crores in phases to establish an API manufacturing facility in Andhra Pradesh. The MOU is non-binding and valid for 12 months, subject to requisite approvals and statutory clearances.
Strategic Expansion into Andhra Pradesh
Blue Jet Healthcare Limited has entered into a significant Memorandum of Understanding (MOU) with the Andhra Pradesh Economic Development Board (APEDB), Government of Andhra Pradesh. This strategic move signals the company’s intention to expand its manufacturing footprint by proposing a substantial investment in the state.
Proposed API Manufacturing Facility
Under the terms of the MOU, Blue Jet Healthcare is evaluating the acquisition of 50 acres of land in Andhra Pradesh. This land will be utilized for setting up a new API (Active Pharmaceutical Ingredient) Manufacturing Facility. The estimated investment for this project is pegged at ₹500 crores, to be deployed in phases. This expansion is expected to bolster the company’s production capabilities and its presence in the pharmaceutical sector.
MOU Details and Next Steps
The MOU, signed on November 13, 2026, is a non-binding agreement and will remain valid for a period of 12 months from the date of its signing. The successful implementation of the project is contingent upon securing necessary approvals, statutory clearances, and the formal approval from the Board of Directors of Blue Jet Healthcare. The company will make this information publicly available on its website, www.bluejethealthcare.com.
Source: BSE
